Efficacy and tolerability of once-daily barnidipine in the clinical management of patients with mild to moderate essential hypertension

Blood Pressure

Volumn 7, Issue SUPPL. 1, 1998, Pages 15-21

  Spieker, Claus ^a  

^a Raphaels Klinik Munster GmbH   (Germany)

Author keywords

adverse events barnidipine; blood pressure; calcium antagonist; clinical trial; efficacy

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DRUG DERIVATIVE; MEPIRODIPINE; NIFEDIPINE; AMLODIPINE; NITRENDIPINE;

ARTICLE; CLINICAL TRIAL; HUMAN; HYPERTENSION; MULTICENTER STUDY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE MONITORING; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EDEMA; ESSENTIAL HYPERTENSION; HEADACHE; HEART PALPITATION; MAJOR CLINICAL STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CLINICAL TRIALS; HUMANS; HYPERTENSION; MULTICENTER STUDIES; NIFEDIPINE; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0031816905     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/080370598438555     Document Type: Conference Paper

References (13)

1. Zanchetti A, Chalmers J, Arakawa K, et al. Guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 1993; 11: 905-18. (Pubitemid 23277465)
2. MacMahon S, Rodgers A. The effects of antihypertensive treatment on vascular disease: reappraisal of evidence in 1994. Trends Vasc Med 1994; 4: 265-71.
3. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke and coronary heart disease. I. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765-74. (Pubitemid 20106689)
4. Bühler FR, Distler A, Laragh JH, Tourkantoris D, Valdes G, Wever MA. Place of calcium antagonists in antihypertensive therapy. J Cardiovasc Pharmacol 1984; 6 (Suppl 7): S929-92.
5. Struyker-Boudier HAJ, Smits JFM, DeMey JGR. The pharmacology of calcium antagonists: a review. J Cardiovasc Pharmacol 1990; 5 (Suppl 4): S1-10. (Pubitemid 20189523)
6. Collins WCJ, Cullen MJ, Feely J. Calcium channel blocker drugs and diabetic control. Clin Pharmacol Ther 1987; 42: 420-3. (Pubitemid 17165703)
7. Gong L, Zhang W, Zhu Y, et al. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens 1996; 14: 1237-45. (Pubitemid 26343504)
8. Amery A, Birkenhäger W, Bulpitt CJ, et al. Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging 1991; 3: 287-302.
9. Staessen JA, Fagard R, Thijs L, et al. Randomized doubleblind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350 (9080): 757-64. (Pubitemid 27387202)
10. Reid JL, Meredith PA, Donnelly R, Elliot HL. Pharmacokinetics of calcium antagonists. J Cardiovasc Pharmacol 1988; 12 (Suppl 7): S22-6. (Pubitemid 19014181)
11. Satoh H. Pharmacology and therapeutic effects of mepirodipine. Cardiovasc Drug Rev 1991; 9: 340-56.
12. White WB, Schulman P, McCabe EJ, Dey HM. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989; 261: 873-7. (Pubitemid 19046415)
13. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA 1983; 249: 2792-8. (Pubitemid 13093711)